A Randomized Clinical Trial Comparing Revaccination with Pneumococcal Conjugate Vaccine to Polysaccharide Vaccine among HIV‐Infected Adults

Conjugate Vaccine ◽

Polysaccharide Vaccine

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Vaccine ◽

10.1016/j.vaccine.2017.12.061 ◽

2018 ◽

Vol 36 (5) ◽

pp. 606-614 ◽

Cited By ~ 6

Author(s):

Lisa A. Jackson ◽

Hana M. El Sahly ◽

Sarah George ◽

Patricia Winokur ◽

Kathryn Edwards ◽

...

Keyword(s):

Clinical Trial ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

Double Dose ◽

Pneumococcal Polysaccharide Vaccine ◽

Single Versus

A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly

PLoS ONE ◽

10.1371/journal.pone.0094578 ◽

2014 ◽

Vol 9 (4) ◽

pp. e94578 ◽

Cited By ~ 23

Author(s):

C. Raina MacIntyre ◽

Iman Ridda ◽

Zhanhai Gao ◽

Aye M. Moa ◽

Peter B. McIntyre ◽

...

Keyword(s):

Clinical Trial ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

Hospitalized Elderly

Faculty Opinions recommendation of Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718098683.793483322 ◽

2013 ◽

Author(s):

Javier Chinen

Keyword(s):

Clinical Trial ◽

Conjugate Vaccine ◽

Primary Immunization

A single centre randomised clinical trial to assess the antibody response to a 23-valent pneumococcal polysaccharide vaccine administered to adults aged between 50 - 70 years following a 0, 1 or 2 dose priming immunisation with a 7-valent pneumococcal conjugate vaccine

http://isrctn.org/> ◽

10.1186/isrctn78768849 ◽

2013 ◽

Author(s):

Andrew Pollard

Keyword(s):

Clinical Trial ◽

Antibody Response ◽

Conjugate Vaccine ◽

Randomised Clinical Trial ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Single Centre

Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years

Vaccine ◽

10.1016/j.vaccine.2012.10.077 ◽

2013 ◽

Vol 31 (2) ◽

pp. 291-294 ◽

Cited By ~ 10

Author(s):

Tino F. Schwarz ◽

Beate Schmoele-Thoma

Keyword(s):

Clinical Trial ◽

Influenza Vaccine ◽

Conjugate Vaccine ◽

Trivalent Influenza Vaccine

Strain Characteristics ofStreptococcus pneumoniaeCarriage and Invasive Disease Isolates during a Cluster‐Randomized Clinical Trial of the 7‐Valent Pneumococcal Conjugate Vaccine

The Journal of Infectious Diseases ◽

10.1086/521831 ◽

2007 ◽

Vol 196 (8) ◽

pp. 1221-1227 ◽

Cited By ~ 44

Author(s):

Marc Lipsitch ◽

Keith O’Neill ◽

Derrick Cordy ◽

Boris Bugalter ◽

Krzysztof Trzcinski ◽

...

Keyword(s):

Clinical Trial ◽

Conjugate Vaccine ◽

Invasive Disease ◽

Cluster Randomized

A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands

Vaccine ◽

10.1016/j.vaccine.2019.05.065 ◽

2019 ◽

Vol 37 (30) ◽

pp. 4147-4154 ◽

Cited By ~ 7

Author(s):

Bradford D. Gessner ◽

Qin Jiang ◽

Cornelis H. Van Werkhoven ◽

Heather L. Sings ◽

Chris Webber ◽

...

Keyword(s):

Clinical Trial ◽

The Netherlands ◽

Conjugate Vaccine ◽

Vaccine Efficacy ◽

Community Acquired Pneumonia ◽

Post Hoc Analysis ◽

Clinical Community ◽

Post Hoc

A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands

Vaccine ◽

10.1016/j.vaccine.2018.05.097 ◽

2019 ◽

Vol 37 (38) ◽

pp. 5777-5787 ◽

Cited By ~ 13

Author(s):

Bradford D. Gessner ◽

Qin Jiang ◽

Cornelis H. Van Werkhoven ◽

Heather L. Sings ◽

Chris Webber ◽

...

Keyword(s):

Public Health ◽

Clinical Trial ◽

The Netherlands ◽

Conjugate Vaccine ◽

Health Evaluation ◽

Adult Disease ◽

Disease Outcomes ◽

Vaccine Impact

VACCINATING OLDER ADULTS IN JAPAN WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb3 ◽

2016 ◽

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

SAFETY OF A NEW CUBAN PNEUMOCOCCAL CONJUGATE VACCINE: A PHASE I CLINICAL TRIAL IN INFANTS 7 MONTH-OLD

10.26226/morressier.5731f0d7d462b8029237fd99 ◽

2016 ◽

Author(s):

Rinaldo Puga-Gomez

Keyword(s):

Clinical Trial ◽

Phase I ◽

Conjugate Vaccine ◽

Phase I Clinical Trial